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Abstract 
Introduction: Mean platelet volume (MPV) has been shown to reflect the inflammatory burden in different inflammatory and autoimmune 
diseases. Our objective was to analyze the MPV in patients with tuberculous (TBM) and bacterial meningitis (BM). 
Methodology: The demographic and clinical data of 73 consecutive patients that presented with either BM (n = 35) or TBM (n = 38) were 
retrospectively analyzed, as well as that of 28 age- and sex-matched controls. 
Results: MPV was 8.78 ± 1.58 fL in patients with BM and 6.42 ± 1.39 fL in the TBM group (p < 0.05). In the control group, MPV was 7.4 ± 
0.66 fL, significantly higher and lower when compared with TBM and BM, respectively. MPV was significantly associated with diagnosis 
(adjusted OR: 5.15, 95% CI: 1.090–23.7; p = 0.03). With the optimal cut-off value of 7.62 fL, MPV had 82% sensibility and 78% specificity 
for the differential diagnosis of TBM versus BM. Lower platelet counts, higher serum creatinine, higher white blood cell counts, and higher 
blood-cerebrospinal fluid glucose ratio were also predictive of BM. 
Conclusions: Platelet counts were lower and MPV was higher in patients with BM compared to patients with TBM.  Platelet indices, available 
in routine bloodwork, could be useful in the early differential diagnosis of these entities. 
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Introduction 
Platelet activation is an essential step in the 
pathophysiology of immune-mediated diseases. Mean 
platelet volume (MPV), a surrogate marker of the 
platelet function and activation, has been shown to 
reflect the inflammatory burden in different chronic 
diseases [1]. MPV is available in routine complete 
blood cell counts, but until recently, its diagnostic or 
prognostic value in the setting of acute infections had 
been widely ignored.  
Differentiating bacterial from tuberculous 
meningitis remains challenging, especially in settings 
with a high prevalence and where molecular diagnostic 
techniques are not widely available. There is evidence 
that suggests that MPV behaves differently in bacterial 
infections compared to other etiologies, and that 
pulmonary tuberculosis is associated with changes in 
platelet counts and MPV [2,3]. We hypothesized that 
these parameters could be of use in the differential 
diagnosis of bacterial (BM) and tuberculous meningitis 
(TBM). Currently, strong diagnostic models using 
simple clinical and laboratory features exist for the 
differentiation of BM and TBM, but they have not 
included MPV or platelet counts [4]. To the best of our 
knowledge, MPV in patients with meningitis has not 
been previously studied. 
 
Methodology 
Patients 
Patients with confirmed diagnosis of meningitis 
who were admitted to the University Hospital “Jose 
Eleuterio Gonzalez”, in Monterrey, Nuevo Leon, 
between the years 2010 and 2015 were retrospectively 
enrolled in the study. Any follow-up data of the same 
patients over their ensuing outpatient visits to the 
neurology consult of the same institution were 
recorded. The complete medical history, clinical and 
biochemical evaluation, and complete blood cell count 
on admission and on latest follow-up with disease on 
remission were recorded. None of the patients had a 
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history of cardiovascular disease, nor were any taking 
anticoagulation drugs, antiplatelet agents, or aspirin. 
The study was approved by the ethics committee of the 
institution. 
 
Diagnostic criteria 
Diagnostic criteria for TBM and BM were applied 
to all patients. Patients were diagnosed as having TBM 
if M. tuberculosis was isolated in the cerebrospinal fluid 
(CSF, either by culture, Ziehl-Neelsen staining, or 
polymerase chain reaction testing), or if they had a 
clinical diagnosis of meningitis but with negative Gram 
stain and sterile culture and at least one of the 
following: proven tuberculosis in a different site, 
magnetic resonance imaging with basal meningeal 
enhancement, and a good response to anti-tuberculosis 
chemotherapy. Patients were diagnosed as having BM 
if pathogenic bacteria were isolated from CSF (either 
by culture or Gram stain), or if patients had a clinical 
diagnosis of meningitis and either a positive blood 
culture for a bacterial pathogen or all of the following: 
neutrophilic pleocytosis in the CSF, a low concentration 
of glucose in the CSF (< 50% of that in blood), and a 
full recovery without anti-tuberculosis drugs. 
 
Control group 
The control group included 28 age- and sex-
matched healthy subjects (matched to BM group), 
whose records were obtained from the outpatient 
internal medicine clinic of the same institution, with 
complete blood cell counts as part of routine check-ups.  
 
Other laboratory and clinical examinations 
All complete blood cell counts were measured by 
an automatic blood counter in the central laboratory at 
the University Hospital. Blood was collected in 
potassium-ethylenediaminetetraacetic acid tubes and 
measured within 1 hour after venipuncture, based on 
institutional protocol. The range of MPV values in the 
laboratory was between 0 and 99 fL. All other 
biochemical and clinical data were obtained from 
medical records. Systemic inflammatory response 
syndrome (SIRS) on admission was defined as two or 
more of the following criteria: temperature >38°C 
(100.4°F) or < 36°C (96.8°F); heart rate > 90; 
respiratory rate > 20 or PaCO2 < 32 mm; and white 
blood cell (WBC) count > 12,000/mm3, < 4,000/mm3, 
or > 10% bands. Duration of illness was defined as time 
from first appearance of any systemic or neurological 
symptoms to admission. The modified Rankin scale 
was used to score outcome on discharge. 
 
Validation of the Thwaites diagnostic model for TBM 
Thwaites et al. [4,5] devised a diagnostic model 
after finding five factors that were independently 
associated with a diagnosis of TBM when compared 
with BM. The prediction rule gives a numerical score 
and suggests a diagnosis of TBM when the score is ≤ 4 
and of BM when the score is > 4. The following are the 
factors included in this model: age ≥ 36 years (2 points); 
blood WBC count ≥ 15,000 103/mL (4 points); duration 
of illness ≥ 6 days (-5 points); CSF WBC count ≥ 900 
(3 points); and CSF % neutrophils ≥ 75 (4 points). The 
reported sensibility and specificity of this rule to 
distinguish TBM from BM is 93%–100% and 73%–
88%, respectively. This diagnostic model was applied 
to the sample to determine sensitivity, specificity, 
positive predictive value (PPV), and negative predictive 
value (NPV). 
 
Statistical analysis 
All statistical analyses were assessed using the 
SPSS computer program (SPSS version 17.0; IBM, 
Armonk, USA). The two groups were compared by 
univariate analysis using either student’s t-test or the 
Mann-Whitney test for quantitative variables (where 
appropriate) and the Chi-square test for categorical 
variables. Variables that were significantly different 
between TBM and BM were included in a logistic 
regression analysis, which was used to model the 
probability of having TBM. The best cut-off points (the 
value that maximizes sensitivity + specificity) were 
selected using the standard receiver operating 
characteristic (ROC) curve, and reported as area under 
the curve (AUC). All parameters were expressed as 
mean values ± standard deviation, and a p value < 0.05 
was considered statistically significant. 
 
Table 1. Demographic data, mean platelet volume (MPV) and platelet count. 
 Control BM TBM 
n 28 35 38 
Male % 65 60 63 
Age (mean) 42.8 40.4 39.6 
Platelet count (mm3 × 1,000) 275.5 ± 55.3 195.1 ± 71.7*+ 310.9 ± 122.9 
MPV (fL) 7.4 ± 0.66 8.78 ± 1.58*+ 6.42 ± 1.39* 
* p < 0.05 versus control; + p < 0.05 versus TBM; BM: bacterial meningitis; TBM: tuberculous bacterial meningitis. 
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Results 
Patient characteristics 
The demographic characteristics of the patients are 
reported in Table 1. A total of 101 patients were 
included in the analysis: 28 in the control group, 35 in 
the BM group, and 38 in the TM group. Their 
demographic characteristics can be found in Table 1. 
 
MPV 
The values of MPV and platelet counts are shown 
in Table 1. MPV was higher and platelet counts lower 
in BM patients compared to both the TBM and control 
groups. There was no difference in platelet count 
between patients with TBM and the control group. 
MPV was significantly lower in the TBM group 
compared to the control group. Both platelet indices 
were significantly different between TBM and BM 
groups. The AUC in the ROC curve for MPV (Figure 
1) when comparing the TBM and BM groups was 0.888 
(95% CI:  0.802–0.957). With the optimal cut-off value 
of 7.62 fL, MPV had 82% sensibility and 78% 
specificity for the differential diagnosis of TBM versus 
BM (PPV: 84% and NPV: 82%).  
 
Other patient variables 
Besides age, sex, platelet count, and MPV, another 
18 clinical and biochemical variables were included in 
the analysis (Table 2). After univariate analysis, only 
the following factors were found to be statistically 
different between the TBM and BM groups: creatinine 
level on admission, serum sodium on admission, WBC 
count on admission, hemoglobin level on admission, 
blood-CSF glucose ratio, presenting with SIRS, and 
duration of illness. There were, as expected, 
significantly more HIV-infected patients in the TBM 
group. These variables (as well as platelet count and 
MPV) were then included in a logistic regression 
analysis (Table 3), where only MPV, platelet count, 
WBC count, SIRS, and blood-CSF glucose ratio were 
Figure 1. ROC curve for MPV (dark gray), Thwaites rule 
(dotted line) and Thwaites rule + MPV (Thw+MPV, light gray).  
Table 2. Other biochemical and clinical variables. 
 BM TBM 
Serum   
Creatinine (mg/dL)        1.33 ± 1.3 0.7 ± 0.2* 
Serum albumin (g/dL)    3.3 ± 1 3.21 ± 0.8 
WBC (1,000/uL)  14.5 ± 6.2 9.9 ± 4.5* 
Hemoglobin (g/dL)   14 ± 2 12.5 ± 1.9* 
Serum lactate (mmol/L)          2.3 ± 2.7 1.6 ± 1 
Serum sodium (mmol/L)     139.3 ± 3.7 134.5 ± 6.5* 
CSF   
Protein (mg/dL)            179 ± 181 358.2 ± 717 
Blood-CSF glucose ratio 0.37 ± 0.2 0.23 ± 0.13* 
WBC (mm3)   337 ± 462 141 ± 169 
Lactate (mmol/L)      4.8 ± 4.3 5.6 ± 2.3 
Clinical   
Duration of illness  5.5 ± 4.7 12.2 ± 11.9* 
HIV, n (%)  2 (6) 11 (29)* 
Headache, n (%)   19 (54) 26 (68) 
Fever, n (%)    26 (74) 23 (61) 
Neck stiffness, n (%)  23 (66) 18 (47) 
Seizures, n (%)  4 (12) 5 (13) 
SIRS, n (%)     25 (71) 8 (21)* 
mRS (discharge)  1.5 ± 2.1 2.1 ± 2.4 
* p < 0.05 versus TBM; BM: bacterial meningitis; TBM: tuberculous bacterial meningitis; WBC: white blood cell; CSF: cerebrospinal fluid; HIV: human 
immunodeficiency virus; SIRS: systemic inflammatory response syndrome; mRS: modified Rankin Scale. 
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found to be significantly correlated with the differential 
diagnosis of TBM versus BM. 
 
Thwaites prediction rule 
Using the Thwaites model, 28 out of 38 cases were 
correctly classified as TBM (74%), while only 17 out of 
35 cases were correctly identified as BM (48%). The 
PPV was 58.3% and the NPV was 66.7% (AUC: 0.652, 
95% CI: 0.503–0.800). Only 3 patients in the whole 
sample (both with BM) had CSF WBC counts over 900. 
In this study, age was not different between groups. On 
the other hand, 13 patients predicted to have BM had a 
disease duration ≥ 6 days. 
When the cutoff MPV value of 7.62 fL was added 
to the model as a dichotomic weighted variable (≥ 7.6 
added 2 points to the score), the sensibility dropped to 
72.4% and specificity rose to 75%. The PPV was 75% 
and the NPV was 72.4% (AUC: 0.732, 95% CI: 0.598–
0.870). Only 6 patients predicted to have BM by the 
Thwaites model had an MPV value below 7.62 fL. The 
AUC of MPV alone was higher than either prediction 
rule (Figure 1). 
 
Discussion 
Platelet activation is an essential step in the 
pathophysiology of diseases associated with thrombosis 
and inflammation. MPV is one of the most widely used 
surrogate markers of the platelet function, reflecting the 
platelet production rate, activity, and stimulation [1,6]. 
It is generated in routine complete blood count tests. It 
has been shown to reflect the inflammatory burden in 
different chronic diseases, and large platelets are 
thought to indicate increased aggregability [1,6]. 
Additionally, overproduction of pro-inflammatory 
cytokines and acute phase reactants can suppress the 
size of platelets by interfering with megakaryopoiesis 
[7]. Thus, alterations in MPV could indicate both a pro-
thrombotic state and an inflammatory state.  
In chronic systemic inflammatory diseases, such as 
active rheumatoid arthritis, inflammatory bowel 
disease, vasculitis, and ankylosing spondylitis, MPV 
has been shown to be low, to correlate with disease 
severity, and even to increase after anti-inflammatory 
therapy [8-10,1]. However, in studies of acute 
infectious diseases, there have been conflicting results. 
Bacterial bloodborne infections and acute bacterial 
sepsis have been associated with elevated MPV, a 
finding with prognostic significance [2,11]. In another 
study of 58 cirrhotic patients with acute ascitic fluid 
infection also found that they had elevated MPV 
compared to non-infected patients [12]. However, in a 
study of 196 children with community-acquired 
pneumonia, a lower MPV was found compared to 
healthy controls [13], a finding later replicated in 
children with respiratory syncytial virus infection [14].  
In our study, BM was associated with a lower 
platelet count and a higher MPV. These patients also 
had higher creatinine and WBC counts and presented 
more often with SIRS, which supports the above-
mentioned findings in patients with bacteremia and 
acute bacterial sepsis [2,11]. Moreover, critical illness 
severity is often correlated with thrombocytopenia, and 
in the case of sepsis, disseminated intravascular platelet 
activation may occur [15]. Both thrombocytosis and 
thrombocytopenia are known to occur in children with 
meningitis. In a study involving 311 children with BM, 
49% developed reactive thrombocytosis during the first 
week of illness, possibly due to inflammatory cytokines 
[16]. On the other hand, thrombocytopenia is a well-
known negative prognostic factor in BM both in 
children and adults [16-18]. In the largest prospective 
study to date involving 696 episodes of bacterial 
meningitis in adults, the mean platelet count was 
198,000 ± 100,000 [18]. Although this value fell within 
normal range and was similar to our findings, lower 
platelet counts were significantly associated with a 
worse prognosis. 
Reactive thrombocytosis has been known to be 
quite common in patients with tuberculosis for some 
time. Thrombocytosis in tuberculosis patients also 
correlates well with markers of inflammation such as 
serum C-reactive protein and erythrocyte sedimentation 
rate [19]. Platelets also show increased aggregability 
and mediators of thrombopoiesis are increased. A study 
of 82 patients with pulmonary tuberculosis found an 
elevated MPV compared to controls and also a 
Table 3. Multivariate analysis of factors associated with the differential diagnosis between TBM and BM. 
 Odds ratio 95% confidence interval P 
Platelet count 0.971 0.947–0.996 0.03 
MPV 5.15 1.090–23.7 0.03 
WBC 1.32 1.052–1.666 0.03 
Blood-CSF glucose ratio 1.08 1.02–1.164 0.03 
SIRS 11.4 1.520–92.7 0.04 
TBM: tuberculous bacterial meningitis; BM: bacterial meningitis; MPV: mean platelet volume; WBC: white blood cells; CSF: cerebrospinal fluid; SIRS: 
systemic inflammatory response syndrome. 
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correlation between MPV and radiological disease [20]. 
When compared to patients with bacterial pneumonia, 
pulmonary tuberculosis patients showed higher MPV 
and platelet counts [3]. However, other studies have 
found contrasting results. In a study of 22 patients with 
intestinal tuberculosis, MPV was lower than that of 
controls and similar to that of patients with 
inflammatory bowel disease [21]. Another recent study 
involving 82 patients with pulmonary tuberculosis 
found lower MPV compared to that of healthy controls, 
and no association between MPV and severity of 
radiological involvement [22]. In support of these 
previous findings, our patients with TBM had lower 
MPV and higher platelet counts compared with those of 
controls and BM patients. 
With respect to a possible mechanism explaining 
our findings, both BM and TBM are associated with an 
intense inflammatory state (increased oxidative stress, 
pro-inflammatory cytokine production, and 
inflammatory cell activation) as well as with a pro-
thrombotic state (endothelial dysfunction, vasculitis, 
and pro-coagulant mediators) [23-26]. Longer disease 
duration in TBM could result in an altered 
megakaryopoiesis due to chronic exposure to an 
inflammatory environment. Further studies are needed 
to establish if other mediators, specific to bacterial or 
tuberculous infection, could also play a significant role. 
In our study, hyponatremia was much more 
common in TBM than in BM, but did not reach 
statistical significance on multivariate logistic 
regression analysis. The association between 
hyponatremia and TBM has been established for some 
time, with over 50% of patients presenting with 
hyponatremia and evidence of syndrome of 
inappropriate secretion of antidiuretic hormone in both 
adult and pediatric series [27,28]. Other proposed 
mechanisms are adrenal insufficiency and cerebral salt-
wasting. In a comparative study of over 500 patients 
with either TBM or BM, serum sodium levels were 
found to be lower in the TBM group, and to be 
independently predictive of a TBM diagnosis [29]. 
Thwaites et al. developed a prediction rule with 
over 90% of sensitivity and sensibility; this was 
obtained for differentiating tuberculous from other 
types of meningitis, including BM, based on clinical 
and laboratory features [4,5]. Five features were 
predictive of a diagnosis of tuberculous meningitis: age, 
length of history (duration of illness), WBC count, total 
CSF white-cell count, and CSF neutrophil proportion. 
Several studies have confirmed these findings [30] and 
added other discriminating features such as protein 
count, headache [31], and focal deficit [32]. In our 
series, of these factors, only length of history and WBC 
count were significantly different between groups.  
Platelet count and MPV had the lowest p values on 
univariate analysis and the largest areas under the curve 
on ROC of all the features studied. Furthermore, we 
found other significant differences, such as SIRS, 
creatinine level, and blood-CSF glucose ratio. When we 
applied the Thwaites prediction rule to our sample, the 
sensitivity and sensibility was much lower than the 
figures reported originally. This can be explained by the 
differences between the factors we identified as 
significant in our study and those identified by Thwaites 
et al., as well as by other epidemiological factors that 
could be specific to our population. Another possible 
confounding factor is the prevalence of HIV infection 
in our sample, but studies on MPV in this setting are 
controversial as well. In a study of 234 patients with 
HIV infection, MPV was lower compared with that of 
healthy controls [33], whereas they were found to be 
elevated in asymptomatic HIV-infected and treatment-
naive patients [34]. None of the findings in this paper 
were significantly modified if we excluded HIV-
positive cases (data not shown). Of note, in our series, 
age was not a useful discriminating factor, which is 
consistent with later findings by other groups [32]. The 
sensibility and specificity of the Thwaites prediction 
rule was only mildly improved in accuracy when we 
included MPV values into the rule as a dichotomic 
variable using the optimal cut-off value. The Thwaites 
prediction rule was of limited value in our population.  
This study has several limitations commonly shared 
by retrospective studies. The sample size was small. We 
also did not investigate inflammatory markers or other 
markers of platelet function or aggregability, nor 
mediators such as platelet activating factor, 
thromboxane, or thrombomodulin.  
 
Conclusions 
Platelet counts are lower and MPV is higher in 
patients with BM as opposed to those with TBM.  
Platelet indices, available in simple, inexpensive, and 
routine bloodwork, could be useful in the early 
differential diagnosis of these entities, particularly if 
combined with other established predictors. 
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